Valeant Pharmaceuticals International (VRX) Stock News, Earnings & History

(NYSE:VRX) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 153.10
52wk low: 95.28
EPS: -2.63
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 37.93B
Avg Vol (3m): 3.26M

Latest Headlines

Insider Trading Cheat Sheet

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chai-Onn Robert Roswell EVP, Gen. Couns. & Corp. Secy. Jun 23 Option Exercise 6.45 10,203 65,809 34,202 Jun 24 04:37 PM
Chai-Onn Robert Roswell EVP, Gen. Couns. & Corp. Secy. Jun 23 Sale 121.70 10,203 1,241,676 23,999 Jun 24 04:37 PM
Mirovsky Pavel President of Valeant Europe Jun 02 Sale 131.25 10,000 1,312,486 0 Jun 04 03:19 PM
Chai-Onn Robert Roswell EVP, Gen. Couns. & Corp. Secy. May 13 Option Exercise 6.45 10,000 64,500 33,999 May 14 04:29 PM
Chai-Onn Robert Roswell EVP, Gen. Couns. & Corp. Secy. May 13 Sale 130.08 10,000 1,300,836 23,999 May 14 04:29 PM
Provencio Norma Ann Director Apr 01 Sale 132.18 5,000 660,886 137,495 Apr 02 04:55 PM
Kornwasser Laizer EVP, Company Group Chairman Mar 21 Buy 134.97 2,481 334,859 53,582 Mar 25 01:06 PM
Chai-Onn Robert Roswell EVP, Gen. Couns. & Corp. Secy. Mar 17 Option Exercise 6.45 5,000 32,250 28,999 Mar 19 04:33 PM
Chai-Onn Robert Roswell EVP, Gen. Couns. & Corp. Secy. Mar 17 Sale 141.72 5,000 708,600 23,999 Mar 19 04:33 PM
Weldon Ryan EVP, Company Group Chairman Feb 11 Option Exercise 0.00 11,000 0 103,823 Feb 12 04:43 PM

Fundamental Cheat Sheet


* The data is daily updated on 5:30PM EST

Yahoo, HV, Market Watch, The Wall St. Journal